60 Day FRN

31204

Federal Register / Vol. 90, No. 132 / Monday, July 14, 2025 / Notices

Authority: 5 U.S.C. 552b (e)(1).
Dated: July 9, 2025.
Stefanie George,
Acting General Counsel, Federal Retirement
Thrift Investment Board.
[FR Doc. 2025–13038 Filed 7–11–25; 8:45 am]
BILLING CODE P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–25–0978; Docket No. CDC–2025–
0057]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Emerging
Infections Program (EIP). The EIP is a
population-based surveillance program
that collects data via active, laboratory
case findings and is used for detecting,
identifying, and monitoring emerging
pathogens.

SUMMARY:

CDC must receive written
comments on or before September 12,
2025.

DATES:

You may submit comments,
identified by Docket No. CDC–2025–
0057 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and

khammond on DSK9W7S144PROD with NOTICES

ADDRESSES:

VerDate Sep<11>2014

23:14 Jul 11, 2025

Jkt 265001

Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road, NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or

PO 00000

Frm 00045

Fmt 4703

Sfmt 4703

other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Emerging Infections Program (OMB
Control No. 0920–0978, Exp. 9/30/
2027)—Revision—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs
(EIPs) are population-based centers of
excellence established through a
network of state health departments
collaborating with academic
institutions; local health departments;
public health and clinical laboratories;
infection control professionals; and
healthcare providers. EIPs assist in
local, state, and national efforts to
prevent, control, and monitor the public
health impact of infectious diseases.
Activities of the EIPs fall into the
following general categories: (1) active
surveillance; (2) applied public health
epidemiologic and laboratory activities;
(3) implementation and evaluation of
pilot prevention/intervention projects;
and (4) flexible response to public
health emergencies. Activities of the
EIPs are designed to: (1) address issues
that the EIP network is particularly
suited to investigate; (2) maintain
sufficient flexibility for emergency
response and new problems as they
arise; (3) develop and evaluate public
health interventions to inform public
health policy and treatment guidelines;
(4) incorporate training as a key
function; and (5) prioritize projects that
lead directly to the prevention of
disease.
A Revision is being submitted to make
existing collection instruments clearer,
consolidate forms and to add new
forms. These forms will allow the EIP to
better detect, identify, track changes in
laboratory testing methodology, gather
information about laboratory utilization
in the EIP catchment area to ensure that
all cases are being captured, and survey
EIP staff to evaluate program quality.
CDC requests OMB approval for an
estimated 40,731 burden hours. There is
no cost to respondents other than their
time to participate.

E:\FR\FM\14JYN1.SGM

14JYN1

31205

Federal Register / Vol. 90, No. 132 / Monday, July 14, 2025 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

ABCs Case Report Form .......................
ABCs Invasive Pneumococcal Disease
in Children and Adults Case Report
Form.
ABCs Neonatal Infection Expanded
Tracking Form.
FoodNet Campylobacter ........................
FoodNet Cyclospora ..............................
FoodNet Listeria monocytogenes ..........
FoodNet Salmonella ..............................
FoodNet Shiga toxin producing E. coli ..
FoodNet Shigella ...................................
FoodNet Vibrio .......................................
FoodNet Yersinia ...................................
FoodNet Hemolytic Uremic Syndrome ..
FoodNet Clinical Laboratory Practices
and Testing Volume.
FluSurv-Net Influenza Hospitalization
Surveillance Network Case Report
Form.
FluSurv-Net Influenza Hospitalization
Surveillance Project Vaccination
Phone Script and Consent Form
(English/Spanish).
FluSurv-Net Influenza Hospitalization
Surveillance Project Provider Vaccination History Fax Form (Children/
Adults) and notification letter.
FluSurv-NET Laboratory Survey ............
HAIC-Multi-site Gram-Negative Surveillance Initiative (MuGSI) Case Report
Form (CRF).
HAIC MuGSI CA CP–CRE Health interview.
HAIC MuGSI Supplemental Surveillance
Officer Survey.
HAIC-Invasive Staphylococcus aureus
Infection Case Report Form.
HAIC-Invasive Staphylococcus aureus
Laboratory Survey.
HAIC-Invasive Staphylococcus aureus
Supplemental Surveillance Officers
Survey.
HAIC-CDI Case Report and Treatment
Form.
HAIC-Annual Survey of Laboratory
Testing Practices for C. difficile Infections.
HAIC-CDI Annual Surveillance Officers
Survey.
HAIC-Emerging Infections Program C.
difficile Surveillance Nursing Home
Telephone Survey (LTCF).
HAIC Candidemia Case Report Form ...
HAIC-Laboratory Testing Practices for
Candidemia Questionnaire.
HAIC Death Ascertainment Project .......
HAIC MuGSI KPC and NDM treatment
collection form.

10
10

984
127

20/60
10/60

3278
212

10

37

20/60

123

10
10
10
10
10
10
10
10
10
10

550
42
16
855
290
234
46
55
10
70

21/60
10/60
20/60
21/60
20/60
10/60
10/60
10/60
1
10/60

1925
70
53
2,993
967
390
77
92
100
117

15

576

25/60

3,600

13

16

10/60

34

13

126

5/60

136

15
11

16
1,581

10/60
29/60

40
8406

10

10

30/60

50

11

1

20/60

4

10

788

29/60

3,809

10

11

9/60

17

10

1

11/60

2

10

1,650

38/60

10,450

10

16

17/60

45

10

1

15/60

3

10

45

5/60

38

10
10

170
20

40/60
14/60

1,133
47

10
10

8
60

24
60/60

1,920
600

Total ......................................................................................................................

....................

........................

....................

40,731

State Health Department.

Form No.

ABC.100.1
ABC.100.2
ABC.100.5
FN.200.1
FN.200.2
FN.200.3
FN.200.4
FN.200.5
FN.200.6
FN.200.7
FN.200.8
FN.200.9
FN.200.10
FSN.300.1
FSN.300.2

FSN.300.3

FSN.300.4
HAIC.400.1

HAIC.400.2
HAIC.400.3
HAIC.400.4
HAIC.400.5
HAIC.400.6
HAIC.400.7
HAIC.400.8
HAIC.400.9
HAIC.400.10
HAIC.400.11
HAIC.400.12
HAIC.400.13
HAIC.400.14
khammond on DSK9W7S144PROD with NOTICES

Avg.
burden per
response
(in hours)

Number of
respondents

Type of respondent

VerDate Sep<11>2014

23:14 Jul 11, 2025

Jkt 265001

Form name

PO 00000

Frm 00046

Fmt 4703

Sfmt 4703

E:\FR\FM\14JYN1.SGM

14JYN1

Total
burden
(in hours)

31206

Federal Register / Vol. 90, No. 132 / Monday, July 14, 2025 / Notices

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2025–13102 Filed 7–11–25; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–25–1154; Docket No. CDC–2025–
0058]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Generic
Clearance for CDC/ATSDR Formative
Research and Tool Development. This
information collection request is
designed to allow CDC to conduct
formative research information
collection activities used to inform
aspects of surveillance,
communications, health promotion, and
research project development.
DATES: Written comments must be
received on or before September 12,
2025.
SUMMARY:

You may submit comments,
identified by Docket No. CDC–2025–
0058 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal

khammond on DSK9W7S144PROD with NOTICES

ADDRESSES:

VerDate Sep<11>2014

23:14 Jul 11, 2025

Jkt 265001

(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT:

To

request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email:
omb@cdc.gov.
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
respond, including through the use of
automated, electronic, mechanical, or
other technological collection
techniques or other forms of information
technology; e.g., permitting electronic
submissions of responses; and
5. Assess information costs.

SUPPLEMENTARY INFORMATION:

Proposed Project
Generic Clearance for CDC/ATSDR
Formative Research and Tool
Development (OMB Control No. 0920–
1154, Exp. 3/31/2026)—Extension—
Office of Science (OS), Centers for
Disease Control and Prevention (CDC).

PO 00000

Frm 00047

Fmt 4703

Sfmt 4703

Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) requests approval for
an Extension of a Generic Clearance for
CDC/ATSDR Formative Research and
Tool Development. This information
collection request is designed to allow
CDC to conduct formative research
information collection activities used to
inform many aspects of surveillance,
communications, health promotion, and
research project development at CDC.
Formative research is the basis for
developing effective strategies including
communication channels, for
influencing behavior change. It helps
researchers identify and understand the
characteristics, interests, behaviors and
needs of target populations that
influence their decisions and actions.
Formative research is integral in
developing programs, as well as
improving existing and ongoing
programs. Formative research looks at
the community in which a public health
intervention is being or will be
implemented and helps the project staff
understand the interests, attributes and
needs of different populations and
persons in that community. Formative
research occurs before a program is
designed and implemented, or while a
program is being conducted.
At CDC, formative research is
necessary for developing new programs
or adapting programs that deal with the
complexity of behaviors, social context,
cultural identities, and health care that
underlie the epidemiology of diseases
and conditions in the U.S. CDC
conducts formative research to develop
public-sensitive communication
messages and user-friendly tools prior to
developing or recommending
interventions, or care. Sometimes these
studies are entirely behavioral but most
often they are cycles of interviews and
focus groups designed to inform the
development of a product.
Products from these formative
research studies will be used for
prevention of disease. Findings from
these studies may also be presented as
evidence to disease-specific National
Advisory Committees, to support
revisions to recommended prevention
and intervention methods, as well as
new recommendations.
Much of CDC’s health communication
takes place within campaigns that have
fairly lengthy planning periods and/or
timeframes that accommodate the
standard federal process for approving
data collections. Short-term qualitative
interviewing and cognitive research
techniques have previously proven
invaluable in the development of
scientifically valid and population-

E:\FR\FM\14JYN1.SGM

14JYN1